- Elimination of inhibitors of coagulation factors VIII and IX by children with hemophilia - ten years of experiencisPublication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: CSL627_3001Publication without faculty affiliation
- New era of management of patients with haemophilia - replacement therapy with coagulation factors VIII and IX with an extended half-life (EHL)2019 | Second Faculty of Medicine
- Octocog alfa2014 | Third Faculty of Medicine
- Localization of human coagulation factor VIII (hFVIII) in transgenic rabbit by FISH?TSA: identification of transgene copy number and transmission to the next generation.2008 | Faculty of Science
- Research Report University Hospital for clinical assessment CSL627_1001Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CSL627_3001Publication without faculty affiliation
- Current therapy of children with hemophilia2007 | Second Faculty of Medicine
- Drug profile - emicizumab2021 | Third Faculty of Medicine
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for factor replacement therapy in patients with haemophilia during invasive procedures and surgery2016 | Publication without faculty affiliation
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for replacement treatment of patients with haemophilia during invasive procedures and surgery, 2nd edition, year 20202020 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Musculo-Skeletal Aspects of Haemophilia2015 | First Faculty of Medicine
- Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate((R)): Final report from a prospective study2018 | Second Faculty of Medicine